Related Experiment Video
Updated: May 24, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Alzheimer's dementia: current data review
Suzana Uzun1, Oliver Kozumplik, Vera Folnegović-Smalc
1Vrapce Psychiatric Hospital, Zagreb, Croatia. suzana.uzun@bolnica-vrapce.hr
Collegium Antropologicum
|March 9, 2012
Summary
This review covers Alzheimer
Area of Science:
- Neurology and Geriatric Medicine
- Neurodegenerative Diseases
- Cognitive Impairment Research
Background:
- Alzheimer's dementia is the most prevalent form of dementia, characterized by cognitive decline affecting daily life.
- Diagnosis relies on clinical symptoms, with memory impairment being a key indicator.
- Current treatments focus on managing symptoms rather than prevention.
Purpose of the Study:
- To review current data on Alzheimer's dementia.
- To discuss pharmacotherapy for mild to moderate Alzheimer's disease.
- To explore potential preventive strategies for Alzheimer's dementia.
Main Methods:
- Review of existing clinical data and research studies on Alzheimer's dementia.
- Analysis of pharmacologic interventions, specifically cholinesterase inhibitors.
- Examination of lifestyle factors and their role in disease prevention.
Main Results:
- Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) are first-line treatments for mild to moderate Alzheimer's disease.
- No pharmacologic interventions are currently proven effective for Alzheimer's dementia prevention.
- Healthy lifestyle choices, including education, physical activity, and cholesterol management, show promise in prevention.
Conclusions:
- While effective treatments exist for symptom management, prevention of Alzheimer's dementia remains a critical research area.
- Lifestyle modifications are suggested as a potential strategy to reduce Alzheimer's dementia risk.
- Further research is needed to develop and validate preventive interventions.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...